Ambulatory arterial stiffness index and 24-hour ambulatory pulse pressure as predictors of mortality in Ohasama, Japan by Kikuya, Masahiro et al.
ISSN: 1524-4628 
Copyright © 2007 American Heart Association. All rights reserved. Print ISSN: 0039-2499. Online
Stroke is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX 72514
DOI: 10.1161/01.STR.0000259604.67283.69 
 2007;38;1161-1166; originally published online Feb 22, 2007; Stroke
O’Brien and Yutaka Imai 
Hoshi, Junichiro Hashimoto, Kazuhito Totsune, Hiroshi Satoh, Ji-Guang Wang, Eoin
Metoki, Kei Asayama, Taku Obara, Ryusuke Inoue, Yan Li, Eamon Dolan, Haruhisa 
Masahiro Kikuya, Jan A. Staessen, Takayoshi Ohkubo, Lutgarde Thijs, Hirohito
 Predictors of Mortality in Ohasama, Japan
Ambulatory Arterial Stiffness Index and 24-Hour Ambulatory Pulse Pressure as
 http://stroke.ahajournals.org/cgi/content/full/38/4/1161
located on the World Wide Web at: 
The online version of this article, along with updated information and services, is
 http://www.lww.com/reprints




Fax:Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. 
Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters
  
 http://stroke.ahajournals.org/subscriptions/
Subscriptions: Information about subscribing to Stroke is online at 
 at K.U. Leuven (KUL) on April 23, 2007 stroke.ahajournals.orgDownloaded from 
Ambulatory Arterial Stiffness Index and 24-Hour Ambulatory
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Lutgarde Thijs, MSc; Hirohito Metoki, MD; Kei Asayama, MD, PhD; Taku Obara, MS;
Ryusuke Inoue, MD, PhD; Yan Li, MD, PhD; Eamon Dolan, MD, PhD; Haruhisa Hoshi, MD, PhD;
Junichiro Hashimoto, MD, PhD; Kazuhito Totsune, MD, PhD; Hiroshi Satoh, MD, PhD;
Ji-Guang Wang, MD, PhD; Eoin O’Brien, MD, PhD; Yutaka Imai, MD, PhD
Background and Purpose—Ambulatory arterial stiffness index (AASI) and pulse pressure (PP) are indexes of arterial
stiffness and can be computed from 24-hour blood pressure recordings. We investigated the prognostic value of AASI
and PP in relation to fatal outcomes.
Methods—In 1542 Ohasama residents (baseline age, 40 to 93 years; 63.4% women), we applied Cox regression to relate
mortality to AASI and PP while adjusting for sex, age, BMI, 24-hour MAP, smoking and drinking habits, diabetes
mellitus, and a history of cardiovascular disease.
Results—During 13.3 years (median), 126 cardiovascular and 63 stroke deaths occurred. The sex- and age-standardized
incidence rates of cardiovascular and stroke mortality across quartiles were U-shaped for AASI and J-shaped for PP.
Across quartiles, the multivariate-adjusted hazard ratios for cardiovascular and stroke death significantly deviated from
those in the whole population in a U-shaped fashion for AASI, whereas for PP, none of the HRs departed from the
overall risk. The hazard ratios for cardiovascular mortality across ascending AASI quartiles were 1.40 (P0.04), 0.82
(P0.25), 0.64 (P0.01), and 1.35 (P0.03). Additional adjustment of AASI for PP and sensitivity analyses by sex,
excluding patients on antihypertensive treatment or with a history of cardiovascular disease, or censoring deaths
occurring within 2 years of enrollment, produced confirmatory results.
Conclusions—In a Japanese population, AASI predicted cardiovascular and stroke mortality over and beyond PP and other
risk factors, whereas in adjusted analyses, PP did not carry any prognostic information. (Stroke. 2007;38:1161-1166.)
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Recent reports have highlighted that the stiffness of centralarteries, as reflected by aortic pulse wave velocity, predicts
the incidence of cardiovascular disease over and beyond 24-hour
mean arterial pressure (MAP) and traditional risk factors.1 We
recently proposed the ambulatory arterial stiffness index (AASI)
as a measure reflecting arterial stiffness.2,3 This novel index,
defined as 1 minus the regression slope of diastolic on systolic
blood pressure in individual subjects, can be determined from
24-hour ambulatory blood pressure recordings.2,3 AASI shows
high correlations with several measures of arterial stiffness,
including aortic pulse wave velocity, central and peripheral pulse
pressures, and the systolic augmentation index.3 In the Dublin
Outcome Study,2 both AASI and 24-hour pulse pressure (PP),
with adjustments applied for other risk factors, predicted cardio-
vascular death. Furthermore, compared with the 24-hour PP,
AASI was a stronger predictor of fatal stroke, especially in
normotensive subjects, whereas the opposite was true for 24-
hour PP in relation to cardiac mortality.2 Although AASI might
refine risk stratification based on ambulatory blood pressure
measurements, its use cannot be recommended before the Irish
outcome results2 are replicated in population cohorts of different
ethnic extraction. We therefore investigated in Japanese subjects,
randomly recruited from the population of Ohasama, Japan, to
what extent AASI and 24-hour PP predicted mortality.
Subjects and Methods
Study Population
The institutional review boards of the Tohoku University School of
Medicine and the Department of Health of the Ohasama Municipal
Government approved the study. All participants gave informed,
written consent.
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From 1988 to 1994, we contacted all 2716 subjects age 40 years
or older and living in 3 of 4 Ohasama districts. Subjects who were
not at home during the normal working hours of the study nurses
(n575) and those who were hospitalized (n121) or incapacitated
(n31) were ineligible. Of the remaining 1989 residents, 1552
(78.0%) participated in the baseline examinations and were followed
up. We excluded 10 subjects from the present analysis because their
ambulatory blood pressure recording included less than 8 and 4 hours
during the awake and asleep periods, respectively. Thus, the number
of participants statistically analyzed totaled 1542.4
Data Collection
At public health centers, trained nurses measured anthropometric
characteristics. Body mass index (BMI) was weight in kilograms
divided by height in meters squared. We programmed validated5
ABPM-630 recorders (Nippon Colin) to obtain oscillometric blood
pressure reading at 30-minute intervals throughout the whole day.
We computed the within-subject 24-hour means of the ambulatory
measurements with weights according to the duration of the awake
and asleep periods. Ambulatory hypertension was an awake blood
pressure of at least 135 mm Hg systolic or 85 mm Hg diastolic or the
use of antihypertensive drugs.
From 24-hour recordings edited according to previously published
criteria,6 we computed for each participant the regression slope of
diastolic on systolic blood pressure.2,3 We did not force the regres-
sion line through the origin (intercept0), because during diastole
when flow drops to 0, such a phenomenon does not occur for blood
pressure.7 We defined AASI as 1 minus the regression slope. The
stiffer the arterial tree, the closer the regression slope and AASI are
to 0 and 1, respectively. In addition, from individual recordings and
the same readings as used for AASI, we computed PP as the
difference between the 24-hour systolic and diastolic blood pressures
and 24-hour MAP as 24-hour diastolic blood pressure plus one third
of the 24-hour PP. The “white-coat window”8 was the first hour of
each ambulatory blood pressure recording.
The study nurses administered a standardized questionnaire,
inquiring into each subject’s medical history, intake of medications,
and smoking and drinking habits. For our primary analyses, we
defined smoking as past or present use of tobacco4 and likewise
drinking as past or current consumption of alcoholic beverages. In
sensitivity analyses, we also considered only current smoking and
drinking. Previous cardiovascular disease included stroke, transient
ischemic attack, coronary heart disease, and atrial fibrillation.
Venous blood samples were analyzed by automated enzymatic
methods for total cholesterol and blood glucose. According to published
criteria,9 diabetes mellitus was a fasting or random blood glucose
value of at least 7.0 or 11.1 mmol/L, respectively, or use of
antidiabetic drugs. Hypercholesterolemia was a serum cholesterol
level of at least 5.68 mmol/L (220 mg/dL) or use of lipid-lowering
drugs.
Ascertainment of Events
We ascertained vital status until December 31, 2004, from the
residents’ registration cards, which are the bases for pension and
social security benefits. We obtained cause-of-death information
from the National Japanese Mortality Registry. We verified the
diagnoses on the death certificates against the medical records of
Ohasama Hospital, where 90% of Ohasama residents undergo
regular health check-ups. The end points considered in the present
analysis were death from all causes, cardiovascular (ICD-10 codes
“I”) and noncardiovascular mortality, and mortality from stroke
(ICD-10 codes, “I6”), and cardiac disorders (ICD-10 codes I08, I11,
I21, I22, I24, I25, I35, I42, I44, I46, I47, I49, I50, I60, I61, I63, I64,
and I68).
Statistical Analysis
For statistical analysis, we used SAS software, version 9.1 (SAS
Institute). We compared means and proportions by ANOVA and the
2 statistic, respectively. We evaluated unadjusted associations from
Pearson’s correlation coefficient. To explore the plausibility of the
Cox model in the overall study population, in exploratory analyses
we plotted mortality rates by quartiles of AASI or 24-hour PP while
standardizing for sex and age by the direct method.
Next, we calculated hazard ratios (HRs) by multiple Cox regres-
sion by comparing the risk in each quartile to the overall risk in the
whole cohort. We used deviation from the mean coding10 because
the association between cardiovascular mortality and AASI was
curvilinear. This approach also allows computation of confidence
intervals (CIs) for the HR in each quartile without definition of an
arbitrary reference group. We adjusted the HRs for baseline charac-
teristics, including sex, age, 24-hour MAP, BMI, current and past
smoking and drinking habits, diabetes mellitus, and a previous
history of cardiovascular disease. In fully adjusted models, we also
accounted for PP when analyzing AASI, and vice versa.
By repeat examination of 19 healthy and untreated subjects
(meanSD age, 65.63.0 years; 79.0% women) within an interval
of 5 years (range, 3.1 to 4.6 years), we computed the repeatability
coefficient as twice the SD of the differences between paired
measurements.11 To allow comparison between AASI and 24-hour
PP, we expressed the repeatability coefficients as percentages of
near-maximal biological variation, ie, 4 times the SD of the first
measurement.12
Results
Baseline Characteristics of the Subjects
The 1542 participants included 977 (63.4%) women and 760
(49.3%) patients with ambulatory hypertension, of whom 473
(62.2%) were taking antihypertensive drugs. Mean values
(SD) were 61.710.7 years for age, 0.460.10 U for
AASI, and 51.37.4 mm Hg for 24-hour PP. Table 1 shows
the characteristics of the study population across quartiles of
the AASI distribution. Anthropometric characteristics and
prevalence of a history of cardiovascular disease were differ-
ent between quartiles (P0.03 or less). Diastolic blood
pressure decreased with increasing AASI, whereas systolic
and 24-MAP increased with higher AASI (Table 1). AASI
was not significantly different between women and men (0.46
versus 0.45, P0.16) or between normotensive and hyper-
tensive subjects (0.45 versus 0.46, P0.19). AASI increased
with age (r0.26, P0.001) but decreased with body height
(r0.17, P0.001). There was a positive association be-
tween AASI and 24-hour PP (r0.24, P0.001).
The number of readings available per recording for the
calculation of AASI, 24-hour PP, and 24-hour MAP averaged
44.6. The 50th, 25th, 10th, 5th, and 1st percentile values were
46, 42, 38, 36, and 30, respectively. When we randomly
reduced the number of blood pressure measurements per
recording in steps of 1, only after we excluded 7 readings,
mean AASI significantly departed from the currently reported
values. In the reproducibility study, the repeatability coeffi-
cients for AASI and 24-hour PP were 53.2% and 55.5%,
respectively.
Analysis of Mortality
During follow-up (median, 13.3 years; 5th to 95th percentile
CI, 4.7 to 16.3 years), 19 024 person-years accrued. Of 345
deaths, 126 (36.5%) were cardiovascular, including 63 stroke
and 59 cardiac. Stroke deaths were due to cerebral infarction
in 38 subjects, intracerebral or subarachnoid hemorrhage in
22, and other cerebrovascular or ill-defined causes in 3.
Cardiac mortality included myocardial infarction (n20),
chronic coronary heart disease (n4), heart failure (n15),
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sudden death (n6), arrhythmia (n6), and various other
cardiac disorders (n8).
Across quartiles, exploratory analyses revealed U-shaped
associations of the sex- and age-standardized incidence rates
of cardiovascular and stroke mortality for AASI and J-shaped
associations for PP (Figure 1). Next, we computed the HRs
for quartiles of AASI and PP, unadjusted (Table 2) and while
adjusting for sex, age, BMI, 24-hour MAP, past and current
smoking and drinking habits, diabetes mellitus, and a previ-
ous history of cardiovascular disease (Figure 2). With such
adjustments applied, for AASI, multiple Cox regression
confirmed U-shaped deviations in the risk of cardiovascular
and stroke mortality across quartiles relative to the risk in the
whole cohort. For 24-hour PP, the adjusted HRs in the
quartiles did not significantly (P0.20) depart from the risk
in the whole population (Figure 2). When we additionally
adjusted AASI for 24-hour PP, and vice versa, our findings
remained consistent (Table 2). In adjusted (Figure 2) and
fully adjusted (Table 2) analyses, we did not find any
association of cardiac or noncardiovascular mortality with
AASI or PP (data not shown).
In sensitivity analyses of cardiovascular mortality in rela-
tion to AASI, we considered women and men separately, we
excluded patients taking antihypertensive drugs at baseline or
those with a history of cardiovascular disease or diabetes
mellitus, we adjusted for current instead of ever-drinking and
ever-smoking, or we additionally adjusted for clinic blood
pressure, systolic blood pressure during the white-coat win-
dow,8 serum cholesterol, or hypercholesterolemia (Table 3).
Furthermore, to exclude reverse causality, we also censored
deaths occurring within 2 years of enrollment (Table 3).13 We
also compared HRs across quartiles, with the quartile with the
lowest risk as the referent group. All sensitivity analyses were
confirmatory. Notably, none of the interaction terms between
sex and the design variables coding for the quartiles reached
significance (P0.20).
Discussion
In middle-aged and older subjects recruited from a Japanese
population, AASI, a measure of the dynamic relation between
diastolic and systolic blood pressure throughout the day,2,3
predicted cardiovascular and stroke mortality over and be-
yond 24-hour MAP, anthropometric characteristics, and car-
diovascular risk factors. With similar adjustments applied,
24-hour PP lost its prognostic value. AASI remained a
significant predictor of cardiovascular and stroke mortality
even in fully adjusted models, which also incorporated
24-hour PP. Our findings extend the validation of AASI
against fatal outcomes from the hypertensive patients en-
rolled in the Dublin Outcome Study2 to a general population
of Japanese extraction.
AASI as a Predictor of Stroke Mortality
In line with the present observations, in the Dublin Outcome
Study,2 AASI also behaved as a stronger predictor of stroke
mortality than did 24-hour PP. However, in the Irish patients,2
TABLE 1. Clinical Characteristics Across Quartiles of AASI
AASI Quartile Limits
0.16–0.38 0.39–0.45 0.45–0.51 0.52–0.82 P Value
No. of subjects 385 386 385 386
Women, % 58.4 62.7 69.6 62.7 0.017
Age, y 57.610.5 61.110 63.410.8 64.510.2 0.0001
BMI, kg/m2 24.13.2 23.63 23.62.9 23.13.1 0.0001
Body height, cm 154.28.6 152.58.6 150.48.9 150.68.6 0.0001
Risk factors
Current/past smokers, % 20.5/2.6 21.0/2.9 15.6/2.3 16.8/4.9 0.14/0.2
Current/past drinkers, % 25.8/0.0 24.3/0.3 18.7/1.0 21.2/1.9 0.15/0.04
Hypertension, %* 44.9 50.8 53.0 48.5 0.14
Diabetes mellitus, %† 18.4 17.4 17.4 16.3 0.90
Previous cardiovascular disease, % 6.8 3.6 6.2 8.8 0.032
Previous stroke, % 6.0 3.1 4.7 7.0 0.08
Hypercholesterolemia, %‡ 22.3 24.6 26.5 21.5 0.35
Serum total cholesterol, mmol/L 5.00.8 5.00.8 5.00.9 5.00.9 0.75
24-hour ambulatory measurements, mm Hg
Systolic pressure 121.612.3 123.513.3 123.812.9 124.213.5 0.031
Diastolic pressure 72.77.3 72.87.7 71.87.5 70.68.1 0.0001
PP 48.96.8 50.77.2 527.2 53.67.6 0.0001
MAP 898.7 89.79.3 89.29.1 88.49.6 0.28
Larger values of AASI indicate stiffer arteries. Plus-minus values are meanSD. P values are for overall differences across quartiles.
*Hypertension was an awake blood pressure of at least 135 mm Hg systolic or 85 mm Hg diastolic or the use of antihypertensive drugs.
†Diabetes mellitus was a fasting or random blood glucose value of 7.0 or 11/1 mmol/L, respectively, or the use of antidiabetic
drugs.
‡Hypercholesterolemia was a serum cholesterol level of 5.68 mmol/L (220 mg/dL) or the use of lipid-lowering drugs.
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the association between stroke mortality and AASI was
log-linear, whereas in the current study, it was U-shaped. We
can only speculate why in Ohasama these associations de-
parted from linearity. First, our study population consisted
mainly of older women (63.4%), whereas among the Irish
patients,2 only 52.8% were female. The proportion of
Ohasama residents with a history of cardiovascular disease in
the second quartile of AASI was about half of that observed
in the bottom and top quartiles. However, the relation
between AASI and cardiovascular mortality remained
U-shaped, even after exclusion of patients with a history of
cardiovascular disease. Residual confounding and/or differ-
ences between European and Asian populations in the com-
peting risks of stroke and coronary heart disease might also
have played a role.14
24-Hour PP as a Predictor of Stroke
In keeping with other studies,15–17 we noticed that in the
Ohasama population, PP did not predict stroke mortality.
Miura and colleagues15 assessed the incidence of fatal and
nonfatal stroke for 10 years in 4989 Japanese (69.5% women;
age range at baseline, 35 to 79 years) in relation to systolic
Figure 1. Sex- and age-standardized rates of cardiovascular
(upper) and stroke (lower) mortality across quartiles of AASI (left)
and 24-hour PP (right). Plotted values along the horizontal axis
are within-quartile means of AASI. The number of deaths is
given for each quartile.
TABLE 2. HRs for Mortality by Quartiles of AASI and 24-Hour PP
Mortality (No. of deaths)
Quartile Limits
AASI 24-Hour PP
0.39 0.39–0.45 0.45–0.51 0.51 45.8 45.8–50.2 50.2–55.6 55.6
All causes (n345)
Unadjusted 0.81 (0.67, 0.99)† 0.87 (0.72, 1.06) 0.90 (0.74, 1.09) 1.57 (1.33, 1.85)* 0.63 (0.50, 0.78)* 0.72 (0.58, 0.89) 1.07 (0.88, 1.29) 2.07 (1.76, 2.43)*
Fully adjusted‡ 1.18 (0.96, 1.45) 0.94 (0.77, 1.14) 0.78 (0.64, 0.95)† 1.16 (0.98, 1.38) 1.08 (0.82, 1.41) 0.98 (0.79, 1.22) 0.91 (0.75, 1.11) 1.04 (0.83, 1.31)
Cardiovascular (n126)
Unadjusted 0.92 (0.67, 1.27) 0.77 (0.55, 1.08) 0.79 (0.56, 1.10) 1.79 (1.37, 2.34)* 0.41 (0.26, 0.66)* 0.75 (0.51, 1.09) 1.05 (0.74, 1.48) 3.08 (2.35, 4.05)*
Fully adjusted‡ 1.41 (1.01, 1.96)† 0.85 (0.61, 1.20) 0.65 (0.46, 0.91)† 1.29 (0.97, 1.70) 0.91 (0.53, 1.55) 1.08 (0.73, 1.60) 0.81 (0.56, 1.16) 1.26 (0.87, 1.82)
Stroke (n63)
Unadjusted 1.02 (0.65, 1.59) 0.81 (0.50, 1.30) 0.61 (0.36, 1.04) 1.99 (1.37, 2.91)* 0.42 (0.21, 0.85)† 0.50 (0.26, 0.97)† 1.25 (0.76, 2.06) 3.76 (2.51, 5.62)*
Fully adjusted‡ 1.56 (0.98, 2.47)‡ 0.89 (0.54, 1.45) 0.52 (0.30, 0.89)† 1.40 (0.94, 2.08) 1.09 (0.49, 2.40) 0.73 (0.37, 1.43) 0.96 (0.58, 1.62) 1.31 (0.76, 2.27)
HRs (95% CIs) express the risk in each quartile vs the overall risk in the whole study population. Fully adjusted models accounted for sex, age, BMI, 24-hour MAP,
past and current smoking and drinking, diabetes mellitus, and previous cardiovascular disease and included both AASI and 24-hour PP.
Significance of HRs: *P0.01, †P0.05, ‡0.05P0.06.
Figure 2. HRs for cardiovascular (upper) and stroke (lower) mor-
tality by quartiles of AASI (left) and 24-hour PP (right), adjusted
for sex, age, 24-hour mean arterial blood pressure, BMI, smok-
ing and drinking habits, diabetes mellitus, and previous history
of cardiovascular disease. The HRs express the risk in each
quartile vs overall risk in the whole population. Horizontal lines
donate 95% CIs. Q1 to Q4 indicate ascending quartiles.
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and diastolic blood pressures, MAP, and PP. The adjusted
HRs for all strokes associated with a 1-SD higher value for
each blood pressure index were 1.68, 1.72, 1.80, and 1.34,
respectively. Benetos and colleagues16 followed up cardio-
vascular mortality for 19.5 years in 19 083 men, age 40 to 69
years. A wider PP, evaluated either by quartiles or on a
continuous scale, was a significant predictor of all-cause,
cardiovascular, and especially coronary mortality, whereas
PP did not predict cerebrovascular mortality. In the study of
Verdecchia et al,17 of 2311 patients with essential hyperten-
sion, adjustment for MAP weakened the association of PP
with the risk of cerebrovascular complications to a nonsig-
nificant level.
AASI as a Proxy for Arterial Stiffness
Taking into account differences in the distributions of sex,
age, and height, average values of AASI in the present
Japanese population were comparable with those observed in
Chinese volunteers,3 a European reference population,2,3 and
a Chinese population.3 AASI rests on the concepts that
arterial distending pressure varies during the day and that the
relation between diastolic and systolic blood pressure, with
this changing distending pressure, largely depends on the
functional and structural characteristics of large arteries. In
addition, AASI must also depend on stroke volume, left
ventricular ejection rate, and the reflection of the arterial
pulse wave. We previously demonstrated in healthy Chinese
volunteers that the correlation coefficient between AASI and
aortic pulse wave velocity was 0.51.3 In a randomly recruited
Chinese population, both before and after adjustment for
arterial wave reflections by considering height and heart rate
as covariates, AASI was correlated better with central and
peripheral systolic augmentation indexes than with 24-hour
PP.3 In 19 healthy and unmedicated study participants who
underwent a repeat ambulatory blood pressure recording
within 5 years of the baseline examination, the repeatability
coefficient expressed as a percentage of nearly-maximum
variation in the first measurement was similar for AASI and
24-hour PP. Despite similar reproducibility, the associations
of cardiovascular and stroke mortality with AASI were closer
than those with 24-hour PP. These findings suggest that from
a physiological point of view, AASI might be more mean-
ingful than 24-hour PP, which in contrast to AASI does not
account for the diurnal variability in the relation between
diastolic and systolic blood pressure.
Study Limitations
The present study must be interpreted within the context of
its potential limitations. First, we did not collect updated
information on nonfatal health outcomes beyond Decem-
ber 31, 2001. Our present analysis, as in the Irish study,2
was therefore exclusively based on mortality. Second,
middle-aged or older women made up the majority of the
Ohasama participants. To some extent, this imbalance in
the sex and age distribution might limit the generalizability
of the current findings. On the other hand, our population-
based survey probably included fewer subjects starting or
continuing antihypertensive drug treatment than in the
Dublin Outcome Study.2 Moreover, we validated the
diagnoses on the death certificates against the medical
records of the only hospital of Ohasama. By censoring
deaths occurring within 2 years of enrollment, we also
TABLE 3. HRs for Cardiovascular Mortality by Quartiles of AASI in Sensitivity Analyses





Quartile 1 Quartile 2 Quartile 3 Quartile 4
Subgroup (No. of subjects analyzed)
Women (n977) 65 1.42 (0.90, 2.24) 0.87 (0.56, 1.37) 0.51 (0.31, 0.83)* 1.59 (1.08, 2.35)*
Men (n565) 61 1.53 (0.93, 2.53) 0.99 (0.61, 1.62) 0.61 (0.37, 1.00)* 1.09 (0.72, 1.66)
Participants not taking antihypertensive
medications (n1069)
55 1.89 (1.17, 3.07)* 0.99 (0.59, 1.66) 0.42 (0.23, 0.76)* 1.27 (0.82, 1.98)
Participants without diabetes mellitus
(n1274)
98 1.44 (0.98, 2.13) 0.78 (0.53, 1.15) 0.72 (0.50, 1.04) 1.24 (0.90, 1.71)
Participants without a history of
cardiovascular disease (n1444)
101 1.68 (1.17, 2.41)* 0.92 (0.64, 1.34) 0.53 (0.35, 0.79)* 1.23 (0.89, 1.69)
Censoring deaths within 2 years of
enrollment (n1542)
115 1.49 (1.05, 2.10)* 0.86 (0.60, 1.22) 0.60 (0.42, 0.87)* 1.30 (0.97, 1.75)
Alternative/additional factors accounted for†
Current instead of ever-smoking and
-drinking (n1542)
126 1.39 (1.00, 1.94) 0.85 (0.60, 1.20) 0.65 (0.46, 0.92)* 1.30 (0.98, 1.72)
Plus clinic systolic blood pressure (n1332) 99 1.59 (1.10, 2.30)* 0.77 (0.53, 1.13) 0.64 (0.43, 0.94)* 1.28 (0.93, 1.76)
Plus systolic blood pressure in the
white-coat window (n1542)
126 1.47 (1.06, 2.05)* 0.90 (0.64, 1.27) 0.64 (0.46, 0.90)* 1.18 (0.89, 1.57)
Plus total cholesterol at baseline (n1542) 126 1.41 (1.01, 1.96)* 0.85 (0.61, 1.20) 0.65 (0.46, 0.91)* 1.29 (0.97, 1.70)
Plus hypercholesterolemia (n1542) 126 1.41 (1.01, 1.96)* 0.85 (0.61, 1.20) 0.65 (0.46, 0.91)* 1.29 (0.97, 1.70)
No. indicates the number of cardiovascular deaths. HRs express the risk in each quartile vs the overall risk in the whole group or subgroup.
Significance of the HRs: *P0.05.
†See fully adjusted models in Table 2.
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excluded the possibility that reverse causality might have
contributed to the present findings.
Perspective
In line with the Dublin Outcome Study in hypertensive
patients,2 we confirmed in a Japanese population that AASI
adds to the stratification of risk based on ambulatory blood
pressure monitoring. AASI can be derived without the need
of complex devices and skilled observers. In previous studies,
we noticed that the upper boundary of the 95% prediction
interval for individual values of AASI in relation to age
ranged from 0.53 at 20 years to 0.72 at 80 years.2,3 A
worldwide consortium of investigators13,18–20 is currently
constructing an international database of ambulatory blood
pressure recordings in relation to cardiovascular outcomes
and will among, other things, further study the predictive
value of AASI in population-based cohorts of different
ethnicity.
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